Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Asthma
Interventions
DRUG

TPI-1020

600 mcg BID x 14 days followed by 1200 mcg BID x 7 days

DRUG

budesonide

400 mcg BID x 14 days then 800 mcg/day x 7 more days

Trial Locations (7)

L8N 3Z5

McMaster University Hospital, Hamilton

K7L 106

Kingston General Hospital, Kingston

H7V 3Y7

CARL, Laval

H2X 2P4

Montreal Chest Institute, Montreal

H4J 1G5

Hopital Sacre Coeur, Montreal

G1S 4L8

Centre Hospitalier St-Sacrement, Ste-Foy

G1V 4G5

Institut Universitaire de Cardiologie et de Pneumologie de l'Hopital Laval, Ste-Foy

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Syntara

INDUSTRY